Pharmaceutical Industry Information Portal


All posts by tag


SINOVAC Announces Positive Data on Booster Dose of CoronaVac®

CoronaVac® generates good immune memory after the second dose. Third dose of CoronaVac® induces strong immune response. No serious adverse reactions reported

SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX

In total, up to 380 million doses of CoronaVac® will be available to both self-financing participants of the Facility as well as those supported by the Gavi COVAX AMC.

Expert Articles